scholarly article | Q13442814 |
P2093 | author name string | Su Yeon Lee | |
Song Iy Han | |||
Ho Sung Kang | |||
Hyun Min Jeon | |||
Cho Hee Kim | |||
Hye Gyeong Park | |||
Min Kyung Ju | |||
Eui Kyong Jeong | |||
P2860 | cites work | A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells | Q24310281 |
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
Links between metabolism and cancer | Q24626229 | ||
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 | ||
Anoikis molecular pathways and its role in cancer progression | Q26852158 | ||
Epithelial-mesenchymal plasticity in carcinoma metastasis | Q26859804 | ||
Glutamine and cancer: cell biology, physiology, and clinical opportunities | Q27011818 | ||
Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism | Q27676639 | ||
On the Origin of Cancer Cells | Q27861025 | ||
Metabolic pathways promoting cancer cell survival and growth | Q28086940 | ||
Developmental functions of the Distal-less/Dlx homeobox genes | Q28201148 | ||
Cancer cell metabolism: Warburg and beyond | Q28293198 | ||
Regulation of cancer cell metabolism | Q28303890 | ||
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells | Q28504783 | ||
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
Bidirectional transport of amino acids regulates mTOR and autophagy | Q29614476 | ||
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress | Q29614493 | ||
Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
WNT signalling pathways as therapeutic targets in cancer | Q29615666 | ||
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction | Q29616653 | ||
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway | Q30480593 | ||
The roles of TGFβ in the tumour microenvironment | Q33630845 | ||
Multiple functions of Dlx genes | Q34075616 | ||
The key role of anaplerosis and cataplerosis for citric acid cycle function. | Q34135762 | ||
Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail | Q34227565 | ||
The NF-κB member p65 controls glutamine metabolism through miR-23a. | Q34277479 | ||
The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism | Q34332654 | ||
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. | Q34787898 | ||
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation | Q34807996 | ||
Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis | Q35235227 | ||
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. | Q35503722 | ||
Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis | Q35591715 | ||
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. | Q35836097 | ||
P53 and prognosis: new insights and further complexity | Q36010518 | ||
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. | Q36435476 | ||
Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma | Q36819620 | ||
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. | Q36850905 | ||
The translational landscape of mTOR signalling steers cancer initiation and metastasis | Q36873513 | ||
p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. | Q36923337 | ||
Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. | Q36989021 | ||
Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response | Q37075390 | ||
SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition | Q37352692 | ||
The Role of Snail in EMT and Tumorigenesis | Q37732532 | ||
Why does cancer therapy lack effective anti-metastasis drugs? | Q38051530 | ||
How cancer metabolism is tuned for proliferation and vulnerable to disruption | Q38059777 | ||
Regulatory networks defining EMT during cancer initiation and progression | Q38076317 | ||
Dealing with hunger: Metabolic stress responses in tumors | Q38162438 | ||
Oncogenic roles of EMT-inducing transcription factors | Q38215948 | ||
Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype | Q38492614 | ||
Dlx-2 is implicated in TGF-β- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation | Q38912972 | ||
The SIRT1/HIF2α axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy. | Q38969475 | ||
The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation | Q39180488 | ||
Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism | Q39341317 | ||
mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways | Q39571848 | ||
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. | Q39636555 | ||
TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. | Q40462552 | ||
Epidermal Snail expression drives skin cancer initiation and progression through enhanced cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential | Q41870134 | ||
Glutaminolysis activates Rag-mTORC1 signaling. | Q52301079 | ||
Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. | Q54406167 | ||
Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis | Q69424697 | ||
Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells | Q71821445 | ||
SnapShot: cancer metabolism pathways | Q86321003 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7925-7939 | |
P577 | publication date | 2016-01-11 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch | |
P478 | volume | 7 |